Ginkgo Bioworks (DNA) Misses Q2 EPS by 36c, Raises Guidance
Get Alerts DNA Hot Sheet
Join SI Premium – FREE
Ginkgo Bioworks (NYSE: DNA) reported Q2 EPS of ($0.41), $0.36 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $145 million versus the consensus estimate of $78.83 million.
GUIDANCE:
Ginkgo Bioworks sees FY2022 revenue of $425-440 million, versus the consensus of $393 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Planet Labs (PL) Reports In-Line Q4 EPS, provides guidance
- Surf Air Mobility Inc. (SRFM) Reports revenue, provides guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!